miR-1/133a clusters cooperatively specify the cardiomyogenic lineage by adjustment of myocardin levels during embryonic heart development

PLoS Genet. 2013;9(9):e1003793. doi: 10.1371/journal.pgen.1003793. Epub 2013 Sep 19.

Abstract

miRNAs are small RNAs directing many developmental processes by posttranscriptional regulation of protein-coding genes. We uncovered a new role for miR-1-1/133a-2 and miR-1-2/133a-1 clusters in the specification of embryonic cardiomyocytes allowing transition from an immature state characterized by expression of smooth muscle (SM) genes to a more mature fetal phenotype. Concomitant knockout of miR-1-1/133a-2 and miR-1-2/133a-1 released suppression of the transcriptional co-activator myocardin, a major regulator of SM gene expression, but not of its binding partner SRF. Overexpression of myocardin in the embryonic heart essentially recapitulated the miR-1/133a mutant phenotype at the molecular level, arresting embryonic cardiomyocytes in an immature state. Interestingly, the majority of postulated miR-1/133a targets was not altered in double mutant mice, indicating that the ability of miR-1/133a to suppress target molecules strongly depends on the cellular context. Finally, we show that myocardin positively regulates expression of miR-1/133a, thus constituting a negative feedback loop that is essential for early cardiac development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Lineage
  • Embryonic Development*
  • Gene Expression Regulation, Developmental
  • Heart / embryology*
  • Mice
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Muscle, Smooth / metabolism
  • Mutation
  • Myocardium / metabolism*
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / metabolism*
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Trans-Activators / genetics
  • Trans-Activators / metabolism
  • Up-Regulation

Substances

  • MIRN133 microRNA, human
  • MicroRNAs
  • Nuclear Proteins
  • Trans-Activators
  • myocardin

Grants and funding

The work was supported by the Max-Planck-Society (URL: www.mpg.de), the Excellence Cluster Cardiopulmonary System (ECCPS) (URL: www.eccps.de), the University of Giessen-Marburg Lung Center (UGMLC) (URL: www.ugmlc.de), and the German Center for Cardiovascular Resaerch (DZHK) (URL: dzhk.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.